Nasim Farrokhnia Moderator

läkare (specialist i internmedicin), medicine doktor (PhD) och MBA
eHälsoläkarföreningen

Nasim Bergman Farrokhnia is a seasoned healthcare executive with extensive experience in internal medicine and digital healthcare innovation. Currently part of Microsoft’s Global Healthcare and Life Sciences team, she is focused on digital transformation in healthcare and has contributed significantly to various healthcare organizations in Sweden.
Professionally, Farrokhnia has held leadership roles in notable digital healthcare providers such as Mindler and Kry/Livi, overseeing quality and research initiatives while expanding services in primary care psychiatry and digital healthcare. She holds a PhD from Uppsala University and has been recognized as one of the top influencers in Swedish tech. Farrokhnia is also a co-founder of a national research network on digital healthcare services and serves in various thought leadership roles within the healthcare sector.

Boubou Hallberg Panelist

CEO of Sahlgrenska University Hospital in Göteborg, Sweden
Sahlgrenska University Hospital

Dr. Boubou Hallberg is CEO of Sahlgrenska University Hospital in Göteborg, Sweden, since August 2023. Dr. Hallberg is a pediatrician and specialist in neonatology. He has previously served as operations manager and chief physician at Karolinska University Hospital in Stockholm, as well as CEO and vice president in the United Arab Emirates for the healthcare group GHP International.

Ida Häggström Panelist

Associate professor/universitetslektor
Chalmers University of Technology

Ida is an Associate Professor in the Computer Vision group at the department of Electrical Engineering at Chalmers University of Technology, working with machine and deep learning techniques for medical image analysis. She collaborates closely with clinical researchers on projects to diagnose, predict and prognosticate different diseases, with a focus on devising new and better problem-solving methods for challenging computer vision tasks in medical imaging.

Kjetil Taskén Panelist

Head of Institute, Professor, MD, PhD
Oslo University Hospital

Kjetil Taskén (M.D., Ph.D.) was appointed Professor of Medicine at University of Oslo (UiO) in 2001 and has since 2018 served as Head of the Institute of Cancer Research, Oslo University Hospital (OUH) Comprehensive Cancer Centre where he is also Group Leader for the Cell Signaling and Immune Regulation Group in the Dept. of Cancer Immunology. He was the Director of the Biotechnology Centre of Oslo, UiO, from 2003 to 2016 and the founding Director of Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, UiO, where he served from 2008 to 2018.
Dr. Taskén has been key in building Norway's national cancer precision medicine initiative, now coordinates the EU Cancer Mission PRIME-ROSE project for DRUP-like clinical trials across Europe and leads the Work Package on treatment in the Joint Action for Precision Cancer Medicine that started end 2025. He has authored>300 publications and is an inventor of >20 patents (h-index >73). He won the King Olav V’s Prize for Cancer Research in 2016, the University of Oslo Innovation Prize in 2023, the Oslo University Hospital Excellent Researcher Award in 2024, and was Vice-President of the Norwegian Academy of Science and Letters 2023-25. Current research is in tumor immune evasion mechanisms and functional precision medicine for different solid and blood cancers.

Petra Noreback Panelist

Statssekreterare
Socialdepartementet

Pia Hardy Panelist

Head of Healthcare & Life Sciences Nordics
Nvidia